Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Laura Jacobsen MD

Laura M. Jacobsen MD

Assistant Professor of Pediatrics, University of Florida College of Medicine; Associate Program Director, Pediatric Endocrinology Fellowship Program, University of Florida, Gainesville, Florida

Dr. Jacobsen is an Assistant Professor in the Department of Pediatrics specializing in the care of children and adolescents with diabetes and endocrine disorders. As a physician-scientist in the University of Florida Diabetes Institute, Dr. Jacobsen also serves as principal investigator and co-investigator on many prevention and intervention clinical trials in type 1 diabetes as well as translational projects studying the immunology of type 1 diabetes including biomarkers of response to therapy. Dr. Jacobsen serves on committees in several international type 1 diabetes consortiums including Type 1 Diabetes TrialNet, The Environmental Determinants of Diabetes in the Young (TEDDY) study, Type 1 Diabetes Exchange-QI Collaborative (T1DX-QI), Network for Pancreatic Organ donors with Diabetes (nPOD), American Diabetes Association Precision Medicine Consensus Working Group, and the International Society for Pediatric and Adolescent Diabetes Guidelines Working Group. Dr. Jacobsen also serves as the Associate Program Director for the Pediatric Endocrinology Fellowship Program at the University of Florida.

Disclosures

Dr. Jacobsen has no relevant disclosures.